Astrazeneca-oxford Vaccine
- All
- News
- Videos
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
-
Serum Institute Pledges $66 Million To Oxford University For Research
Vaccine maker Serum Institute of India (SII) has pledged 50 million pounds ($66.2 million) to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot.
-
12 To 16-Week Gap For Covishield Doses, Says Government
The gap between the first and second doses of the Covishield COVID-19 vaccine can be increased to 12-16 weeks - from the existing six-eight weeks - the government said Thursday, adding that there are no recommended changes in Covaxin dosage interval
-
AstraZeneca Covid Jabs Can Be Used For People Over 65 And Variants: WHO
WHO vaccine experts said Wednesday the AstraZeneca-Oxford Covid-19 vaccine could be used for people aged over 65, and also in settings where variants of the virus are circulating.
-
After Early Hopes AstraZeneca-Oxford Vaccine Suffer Setbacks
The coronavirus vaccine developed in Britain by Oxford University and UK-Swedish pharmaceutical firm AstraZeneca has suffered several setbacks since its development, dampening hopes over its global role in ending the pandemic.
-
India's Serum Institute Inks UN Deal For 1.1 Billion Covid Vaccines To 100 Countries
The Serum Institute of India (SII) and UNICEF have entered into a long-term supply agreement for the AstraZeneca-Oxford 'Covishield' and the Novavax vaccines, with the UN children's agency saying it will have access to up to 1.1 billion doses of vaccines for around 100 countries.
-
EU Authorises Astrazeneca Vaccine: Commission Chief
European Commission chief Ursula von der Leyen announced Friday that the AstraZeneca-Oxford University coronavirus vaccine has been authorised for the EU market, hours after the bloc's drug regulator recommended its approval.
-
Mexico Approves AstraZeneca-Oxford Coronavirus Vaccine
Mexico on Monday authorized the coronavirus vaccine developed by AstraZeneca and the University of Oxford for emergency use in the country, which has one of the world's highest Covid-19 death tolls.
-
82-Year-Old Man First Person To Receive AstraZeneca-Oxford Vaccine In UK
Britain on Monday began rolling out the Oxford-AstraZeneca coronavirus vaccine, a possible game-changer in fighting the disease worldwide, while China raced to inoculate millions with a homegrown prophylactic.
-
US Expects To Approve UK-Backed AstraZeneca-Oxford Vaccine In April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
-
Argentina Approves AstraZeneca-Oxford Covid Vaccine
Argentina has followed Britain to become only the second country to authorize the coronavirus vaccine developed by drug firm AstraZeneca and Oxford University, the government said on Wednesday.
-
AstraZeneca-Oxford Covid Vaccine Cleared By UK As It Fights Mutant Virus
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
-
Serum Institute Pledges $66 Million To Oxford University For Research
Vaccine maker Serum Institute of India (SII) has pledged 50 million pounds ($66.2 million) to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot.
-
12 To 16-Week Gap For Covishield Doses, Says Government
The gap between the first and second doses of the Covishield COVID-19 vaccine can be increased to 12-16 weeks - from the existing six-eight weeks - the government said Thursday, adding that there are no recommended changes in Covaxin dosage interval
-
AstraZeneca Covid Jabs Can Be Used For People Over 65 And Variants: WHO
WHO vaccine experts said Wednesday the AstraZeneca-Oxford Covid-19 vaccine could be used for people aged over 65, and also in settings where variants of the virus are circulating.
-
After Early Hopes AstraZeneca-Oxford Vaccine Suffer Setbacks
The coronavirus vaccine developed in Britain by Oxford University and UK-Swedish pharmaceutical firm AstraZeneca has suffered several setbacks since its development, dampening hopes over its global role in ending the pandemic.
-
India's Serum Institute Inks UN Deal For 1.1 Billion Covid Vaccines To 100 Countries
The Serum Institute of India (SII) and UNICEF have entered into a long-term supply agreement for the AstraZeneca-Oxford 'Covishield' and the Novavax vaccines, with the UN children's agency saying it will have access to up to 1.1 billion doses of vaccines for around 100 countries.
-
EU Authorises Astrazeneca Vaccine: Commission Chief
European Commission chief Ursula von der Leyen announced Friday that the AstraZeneca-Oxford University coronavirus vaccine has been authorised for the EU market, hours after the bloc's drug regulator recommended its approval.
-
Mexico Approves AstraZeneca-Oxford Coronavirus Vaccine
Mexico on Monday authorized the coronavirus vaccine developed by AstraZeneca and the University of Oxford for emergency use in the country, which has one of the world's highest Covid-19 death tolls.
-
82-Year-Old Man First Person To Receive AstraZeneca-Oxford Vaccine In UK
Britain on Monday began rolling out the Oxford-AstraZeneca coronavirus vaccine, a possible game-changer in fighting the disease worldwide, while China raced to inoculate millions with a homegrown prophylactic.
-
US Expects To Approve UK-Backed AstraZeneca-Oxford Vaccine In April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
-
Argentina Approves AstraZeneca-Oxford Covid Vaccine
Argentina has followed Britain to become only the second country to authorize the coronavirus vaccine developed by drug firm AstraZeneca and Oxford University, the government said on Wednesday.
-
AstraZeneca-Oxford Covid Vaccine Cleared By UK As It Fights Mutant Virus
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
